Cohort1: dose level 1
|
Administration route |
intratumoral injection |
Dosage |
125 μg, two times, at one month interval |
Age |
Adult, Older_Adult |
|
Cohort2: dose level 2
|
Administration route |
intratumoral injection |
Dosage |
250 μg, two times, at one month interval |
Age |
Adult, Older_Adult |
|
Cohort3: dose level 3
|
Administration route |
intratumoral injection |
Dosage |
500 μg, two times, at one month interval |
Age |
Adult, Older_Adult |
|
Cohort4: dose level 4
|
Administration route |
intratumoral injection |
Dosage |
1000 μg, two times, at one month interval |
Age |
Adult, Older_Adult |
|